The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2025 | Liquid biopsy: a game-changer in the future treatment of lymphoma
In this video, Sven Borchmann, MD, PhD, University of Cologne, Cologne, Germany, highlights the potential of liquid biopsy as a game-changer in the treatment of lymphoma over the next few years. Dr Borchmann notes that standardization of assays is underway, with both academic and private companies obtaining regulatory approvals, leading to increased availability of these tests. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
